Pharmacokinetic study of low- versus high-dose medroxyprogesterone acetate (MPA) in women Tomoko OhtsuHirofumi FujiiYasutsuna Sasaki ORIGINAL ARTICLE Pages: 1 - 8
Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex Yoshihiro MasudaHiroyuki KobayashiTakao Ohnuma ORIGINAL ARTICLE Pages: 9 - 16
Toxicity of cytostatic drugs to normal bone marrow cells in vitro Britt Sundman-EngbergUlf TidefeltChrister Paul ORIGINAL ARTICLE Pages: 17 - 23
Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo Beverly A. TeicherJulia S. WongDavid Buxton ORIGINAL ARTICLE Pages: 24 - 30
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome Yoshinori NaoeMasamichi InamiKyoichi Shimomura ORIGINAL ARTICLE Pages: 31 - 36
Renal toxicity of the neuron-blocking and mitochondriotropic agent m-iodobenzylguanidine Annemieke KuinMarjanka AaldersLou A. Smets ORIGINAL ARTICLE Pages: 37 - 45
Influence of treatment with aminoglutethimide on plasma and red-blood-cell glutathione status in breast cancer patients Hildegunn BerntsenPer Eystein LønningAsbjørn Svardal ORIGINAL ARTICLE Pages: 46 - 52
Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer Kunihiko KobayashiAyako ShinbaraShouji Kudoh ORIGINAL ARTICLE Pages: 53 - 58
Comparative studies between the effects of mitozolomide and two novel tetrazepinones PYRCL and QUINCL on NIH:OVCAR-3 cells Bertrand Jacques Jean-ClaudeAmir MustafaBrian Leyland-Jones ORIGINAL ARTICLE Pages: 59 - 67
Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology Group Franco M. MuggiaJohn A. BlessingJoel Sorosky ORIGINAL ARTICLE Pages: 68 - 70
Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patients P. BealeI. JudsonM. Walker ORIGINAL ARTICLE Pages: 71 - 76
Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model Henk-Jan GuchelaarIstvan VermesClemens Haanen ORIGINAL ARTICLE Pages: 77 - 83
Phase I clinical and pharmacokinetic study of oral 9-aminocamptothecin (NSC-603071) Sridhar ManiLalitha IyerMark J. Ratain SHORT COMMUNICATION Pages: 84 - 87